SEC Form 3 · accession 0001359824-17-000009
Arno Therapeutics, Inc · ARNI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan J Zucker
10% Owner
Period of report
Dec 30, 2016
Accepted (ET)
Jan 9, 2017 · 12:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001195116
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 4,285,111 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012 Series A Warrants | $1.14 | holding | — | — | — | Oct 29, 2013 | Nov 26, 2017 | Common Stock | 1,605,809 | — | D |
| 2013 Series D Warrants | $1.75 | holding | — | — | — | Oct 29, 2013 | Oct 29, 2018 | Common Stock | 1,383,702 | — | D |